Novel guanidine derivatives targeting leukemia as selective Src/Abl dual inhibitors: Design, synthesis and anti-proliferative activity.

MLA

Moustafa, Amr H., et al. “Novel Guanidine Derivatives Targeting Leukemia as Selective Src/Abl Dual Inhibitors: Design, Synthesis and Anti-Proliferative Activity.” Bioorganic Chemistry, vol. 147, June 2024, p. 107410. EBSCOhost, https://doi.org/10.1016/j.bioorg.2024.107410.

APA

Moustafa, A. H., AboulMagd, A. M., Ali, A. M., Khodairy, A., Marzouk, A. A., Nafady, A., & T M Nemr, M. (2024). Novel guanidine derivatives targeting leukemia as selective Src/Abl dual inhibitors: Design, synthesis and anti-proliferative activity. Bioorganic Chemistry, 147, 107410. https://doi.org/10.1016/j.bioorg.2024.107410

Chicago

Moustafa, Amr H, Asmaa M AboulMagd, Ali M Ali, Ahmed Khodairy, Adel A Marzouk, Ayman Nafady, and Mohamed T M Nemr. 2024. “Novel Guanidine Derivatives Targeting Leukemia as Selective Src/Abl Dual Inhibitors: Design, Synthesis and Anti-Proliferative Activity.” Bioorganic Chemistry 147 (June): 107410. doi:10.1016/j.bioorg.2024.107410.